tiprankstipranks
Hold Rating Amidst Favorable Acquisition Terms and Competitive Pressures for 2seventy bio
PremiumRatingsHold Rating Amidst Favorable Acquisition Terms and Competitive Pressures for 2seventy bio
17d ago
Spotify upgraded, Freshpet downgraded: Wall Street’s top analyst calls
Premium
The Fly
Spotify upgraded, Freshpet downgraded: Wall Street’s top analyst calls
18d ago
Morning Movers: 2seventy Bio skyrockets following acquisition by Bristol Myers
Premium
The Fly
Morning Movers: 2seventy Bio skyrockets following acquisition by Bristol Myers
18d ago
2seventy bio Reports Strong Growth in Abecma Sales
PremiumCompany Announcements2seventy bio Reports Strong Growth in Abecma Sales
5M ago
2seventy bio Reports Strong Q3 with Abecma Growth
Premium
Company Announcements
2seventy bio Reports Strong Q3 with Abecma Growth
5M ago
2seventy Bio reports Q3 EPS (19c), consensus (24c)
Premium
The Fly
2seventy Bio reports Q3 EPS (19c), consensus (24c)
5M ago
2seventy Bio lowers net cash spend range to $40M-60M for FY24
PremiumThe Fly2seventy Bio lowers net cash spend range to $40M-60M for FY24
8M ago
2seventy Bio reports Q EPS 45c, consensus (65c)
Premium
The Fly
2seventy Bio reports Q EPS 45c, consensus (65c)
8M ago
2seventy Bio price target lowered to $6 from $7 at Morgan Stanley
Premium
The Fly
2seventy Bio price target lowered to $6 from $7 at Morgan Stanley
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100